Beta Bionics, Inc. (BBNX) PT Raised to $37 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts BBNX Hot Sheet
Price: $17.43 --0%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 20
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 20
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $37.00 (from $32.00) while maintaining a Buy rating.
You May Also Be Interested In
- First Majestic Silver (AG) PT Lowered to $25.50 at H.C. Wainwright
- Svenska Handelsbanken AB (SHBA:SS) (SVNLY) PT Raised to SEK127 at Citi
- Liontown Resources Ltd (LTR:AU) PT Lowered to AUD0.95 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
